Astragaloside IV suppresses development of hepatocellular carcinoma by regulating miR-150-5p/β-catenin axis
Publication date: Available online 25 April 2020Source: Environmental Toxicology and PharmacologyAuthor(s): Xiang Cui, Xiaoyan Jiang, Chunshan Wei, Yufeng Xing, Guangdong Tong
Source: Environmental Toxicology and Pharmacology - Category: Environmental Health Source Type: research
More News: Cancer & Oncology | Carcinoma | Drugs & Pharmacology | Environmental Health | Hepatocellular Carcinoma | Liver Cancer | Toxicology